Enforcement Report - Week of July 24, 2024
Brassica Pharma Receives FDA Warning Letter
Main Products Issues Voluntary Nationwide Recall of Umary Acido Hialuronico
Hikma Pharmaceuticals Issues Voluntary Nationwide Recall for Acetaminophen Injection
Enforcement Report - Week of July 17, 2024
Jiangsu Hengrui Pharma Receives FDA Warning Letter
YangZhou SuXiang Medical Receives FDA Warning Letter
Shandong Boyuan Pharmaceutical on FDA Import Alert List
SoloVital.com Issues Voluntary Nationwide Recall of Umary Acido Hialuronica
FDA Issues Form 483 to Lonza Group